Radioprotectors in Radiotherapy

Journal of Radiation Research

Volumn 42, Issue 1, 2001, Pages 21-37

  Nair, Cherupally K K ^a   Parida, Dillip K ^b   Nomura, Taisei ^c  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytokines; Cytoprotectors; Free radical scavengers; Radioprotector; Radiotherapy

Indexed keywords

FREE RADICALS;

CYTOKINES; CYTOPROTECTOR; FREE-RADICAL SCAVENGERS; RADIOPROTECTORS;

RADIOTHERAPY;

LETHRINIDAE;

CYTOKINE; RADIOPROTECTIVE AGENT; SCAVENGER;

ANIMAL; CELL PROTECTION; HUMAN; RADIOTHERAPY; REVIEW;

ANIMALS; CYTOKINES; CYTOPROTECTION; FREE RADICAL SCAVENGERS; HUMANS; RADIATION-PROTECTIVE AGENTS; RADIOTHERAPY;

EID: 0347420170     PISSN: 04493060     EISSN: None     Source Type: Journal    
DOI: 10.1269/jrr.42.21     Document Type: Article

References (120)

1. Scholes, G. (1483) Radiation effects on DNA: The Silvanus Thomson memorial lecture April 1982. Br. J. Radiol. 56: 221-231.
2. Pradhan, D. S., Nair, C. K. K. and Sreenivasan, A. (1973) Radiation injury repair and sensitization of microorganisms. Proc. Ind. Natl. Sci. Acad. 39B: 516-530.
3. Dragaric, I. G. and Dragaric, Z. D. (1971) The radiation chemistry of water. pp. 256, Academic Press, New York.
4. Bacq, Z. M. (1965) Chemical protection against ionizing radiation, Charles C Thomas, Springfield, IL.
5. Baraboi, V. A., Beloshiskii, P. V., Krasiuk, A. N. and Korkach, V. I. (1994) Oxygen dependent processes in the irradiated organisms. Fiziol. Zh. 40: 116-128.
6. Biakov, V. M. and Stepanov, S.V. (1997) Mechanism of primary radiobiologic action. Radiat. Biol. Radioecol. 37: 469-474.
7. Fridovich I. (1978) The biology of oxygen radicals. Science 201: 875-880.
8. Utsumi H., Kodama S., Tano K., Hashimoto, M. W. and Watanabe, H. (1998) Establishment and characterization of a hypocatalasemic mouse cell strain. J. Radiat. Res. 39: 165-174.
9. Livesey, J. C. and Reed, D. J. (1987) Chemical protection against ionizing radiation. Adv. Radiat. Res. 13: 285-353.
10. Glowe, P. J., Glick, J. H. and Weiler, C. (1984) Phase I trials of WR 2721 and cisplatinum. Int. J. Radiat. Oncol. Biol. Phys. 10: 1781-1787.
11. Weiss, J. F. (1997) Pharmacologic approaches to protection against radiation induced lethality and other damage. Environ. Health Perspect. 105: 1473-1478.
12. Maisin, J. R. (1998) Bacq and Alexander award lecture-chemical radioprotection : past present and future. Int. J. Radiat. Biol. 73: 443-450.
13. Maisin, J. R., Albert, C. and Henry, A. (1993) Reduction of short term radiation lethality by biological response modifiers given alone or in association with other chemical protectors. Radiat. Res. 135: 332-337.
14. Wasserman, T. H. (1994) Radiotherapeutic studies with amifostine (Ethyol). Semin. Oncol. 21 (Suppl. 11): 21-25.
15. Tannehill, S. P. and Mehta, M. P. (1996) Amifostine and radiation therapy: past, present, and future. Semin. Oncol. 23 (Suppl. 8): 69-77.
16. Valles, E. G., de Castro, C. R. and Castro, J. A. (1995) Radioprotectors as late preventive agents against carbon tetra chloride induced liver necrosis: protection by 2-(3-aminopropylamino) ethyl phosphorothioic acid (WR 2721). Exptl. Molec. Pathol. 63: 101-109.
17. Travis, E. L. (1984) The oxygen dependence of protection by amino thiols: implications for normal tissues and solid tumors. Int. J. Radiat. Oncol. Biol. Phy. 10: 1495-1501.
18. Ramnath, N., Lo Russo, P., Simon, M. and Martino, S. (1997) Phase II evaluation of cisplatin and WR 2721 for refractory metastatic breast cancer. Am. J. Clin. Oncol. 20: 368-372.
19. Capizzi, R. L. and Oster, W. (1995) Protection of normal tissue from the cytotoxic effects of chemotherapy and radiation by amifostine: clinical experiences. Eu. J. Cancer 31A (Suppl. 1): S8-13.
20. Tannehill, S. P., Mehta, M. P., Larson, M, Storer, B., Pellet, J., Kinsella, T. J. and Schiller, J. H. (1997) Effect of amyfostine on toxicities associated with sequential chemotherapy and radiation therapy for unresectable non small cell lung cancer. Results of a phase II trial. J. Clin. Oncol. 15: 2850-2857.
21. Metodiewa, D., Skolimowski, J. and Karolczak, S. (1996) Tempace and troxyl-novel synthesized 2,2,6,6-tetramethylpiperidine derivatives as antioxidants and radioprotectors. Biochem. Mol. Biol. Int. 40: 1211-1219.
22. Hahn, S. M., Deluca, A. M., Coffin, D., Krishna, C. M. and Mitchell, J. B. (1998) In vivo radioprotection and effects on blood pressure of the stable free radical nitroxides. Int. J. Radiat. Oncol. Biol. Phys. 42: 839-842.
23. Hahn, S. M., Krishna, C. M., Samuni, A., DeGraff, W., Cuscela, D. O., Johnstone, P. and Mitchell, J. B. (1994) Potential use of nitroxides in radiation oncology. Cancer Res. 54 (Suppl. 7): 2006S-2010S.
24. Hahn, S. M., Sullivan, F. J., DeLuca, A. M., Bacher, J. D., Liebmann, J., Krishna, M. C., Coffin, D., Mitchell, J. B. (1999) Hemodynamic effect of the nitroxide superoxide dismutase mimics. Free. Radical. Biol. Med. 27: 529-535.
25. Wilson, R. L. (1983) Free radical repair mechanisms and the interaction of glutathione and vitamin C and E. In: Radioprotectors and anticarcinogens, Eds. O. F. Nygaard and M. G. Simic, pp. 1-23, Academic Press, New York.
26. Konopacka, M. (1996) Vitamines as radioprotectors of normal cells. Postepy Hig. Med. Dosw. 50: 145-156.
27. Borek, C., Ong, A., Mason, H., Donahue, L. and Biaglow, J. (1986) Selenium and vitamin E inhibit radiogenic and chemically induced transformation in vitro via different mechanisms. Proc. Natl. Acad. Sci. (USA) 83: 1490-1494.
28. Harapanhalli, R. S., Nara, V. R., Yaghmai, V., Azure, M. T., Goddu, S. M., Howell, R. W. and Rao, D. V. (1994) Vitamins as radioprotectors in vivo: II Protection by vitamin A and soyabean oil against radiation damage caused by internal radionucleides. Radiat. Res. 139: 115-122.
29. Nair, C. K. K., Rajagopalan, R., Wani, K., Huilgol, N. G., Kagiya, V. T. and Kapoor, S. (1999) Mechanism of radioprotection by TMG - a water soluble vitamin E. J. Radiat. Res. 40: 451 (Abstract).
30. Reiter, R. J. (1995) Functional pleotropy of the neurohormone melatonin: antioxidant protection and neuroendocrine regulation. Front. Neuroendocrinol. 16: 383-415.
31. Pierrefiche, G. and Laborit, H. (1995) Oxygen free radicals, melatonin and aging. Exp. Gerontol. 30: 213-227.
32. Pieri, C., Marra, M, Moroni, F., Recchioni, R. and Selli, F. M. (1994) Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sci. 15: 271-276.
33. Vijayalaxmi, R. J. R., Herman, T. S. and Meltz (1996) Melatonin and radioprotection from genetic damage: in vivo/in vitro studies with human volunteers. Mut. Res. 371: 221-228.
34. Badr, F. M., El Habit, O. H. M. and Harraz, M. M. (1999) Radioprotective effect of melatonin assessed by measuring chromosomal damage in mitotic and meiotic cells. Mut. Res. 444: 367-372.
35. Yang, F., Wang, R. and Zhao, Y (1998) Radioprotective effect of E838 to hemopoietic system. Zhongguo-Zhongliu-Linchuang 25: 832-833.
36. Kumar, P., Kuttan, R and Kuttan, G. (1996) Radioprotective effect of Rasayanas. Ind. J. Exp. Biol. 34: 848-850.
37. Hsu, H. Y., Yang, J. J., Ho, Y. H. and Lin, C. C. (1999) Difference in the effects of radioprotection between aerial and root parts of Lycium chinese. J. Ethanopharmacol. 64: 101-108.
38. Uma Devi, P. and Ganasoundari, A. (1999) Modulation of antioxidant enzymes by Ocimum sanctum and its role in protection against radiation injury. Ind. J. Exp. Biol. 37: 262-268.
39. Uma Devi, P., Ganasoundari, A., Rao, B. S. S. and Srinivasan, K. K. (1999) In vivo radioprotection by Ocimum flavanoids: survival of mice. Radiat. Res. 151: 74-78.
40. Chaudhary, D., Chandra, D. and Kale, R. K. (1999) Modulation of radioresponse of glyoxalase system by curcumin. J. Ethanopharmacol. 64: 1-7.
41. Shinoda, M. (1995) Studies on chemical radioprotectors against X-irradiation used by soft X-ray accelerator. Yakugaku Zasshi 115: 24-41.
42. Kamat, J. P., Boloor, K. K., Devasagayam, T. P. A. and Venkatachalam, S. R. (2000) Antioxidant properties of Asparagus racemosus against damage induced by gamma-radiation in rat liver mitochondria. J. Ethnopharmacology 71: 425-135.
43. Zhang, C., Zheng, S., Zhang, Y., Luo, C. and Guo, C. (1997) The protective effective polysaccharide and C-phycocyanin from Spirulina platensis on acute radiation injury in mice. Acta Nutrimenta Sinica 18: 327-331.
44. Moulder, J. E., Fish, B. L. and Cohen, E. F. (1998) Angiotensin II receptor antagonists in treatment and prevention of radiation nephropathy. Int. J. Radiat. Biol. 73: 415-121.
45. Molteni, A., Moulder, J. E., Cohen, E. F., Ward, W. F., Fish, B. L., Taylor, J. M., Wolfe, L. F., Molteni, L. B. and Veno, P. (2000) Control of radiation induced pneumopathy and lung fibrosis by angiotensin converting enzyme inhibitors and angiotensin II type I receptor blocker. Int. J. Radiat. Biol. 76: 523-532.
46. Oikawa, T., Freeman, M., Low, W., Vaughan, D. E. and Fogo, A. (1997) Modulation of plasminogen activator inhibition in vivo: a new mechanism for the antifibrotic effect of renin angiotensin inhibition. Kidney Int. 51: 164-172.
47. Moulder, J. E., Fish, B. L. and Cohen, E. F. (1998) Brief pharmacological intervention in experimental radiation nephropathy. Radiat. Res. 150: 535-541.
48. Ward, W. F., Lin, P. J. P., Wong, P. S., Behnia, R. and Jalali, N. (1993) Radiation pneumonitis in rats and its modification by angiotensin converting enzyme inhibitor captopril evaluated by high resolution computed tomography. Radiat. Res. 135: 81-87.
49. Gauras, I. and Gauras, H. (1487) The use of ACE inhibitors in hypertension. In: Angiotensin Converting Enzyme Inhibitors, Eds. J.B. Kostis and E. De Felice, pp 43-122, Liss, New York.
50. Ward, W. F., Hoellwarth, A. S. and Tuttle, R. D. (1983) Collagen accumulation in irradiated rat lung: modification by D-pencillamine. Radiology 146: 533-537.
51. Moulder, J. E. and Fish, B. L. (1997) Angiotensin converting enzyme inhibitor captopril does not prevent acute gastrointestinal radiation damage in the rat. Radiat.Oncol.Investig. 5: 50-53.
52. Henseley, M. L., Schuchter, L. M., Lindley, C., Meropol, N. J., Cohen, G. I., Border, G., Gradishar, W. J., Green, D. M., Langdon, R. J. Jr., Mitchell, R. B., Negrin, R., Szatrowski, T. P., Thigpen, J. T., Von Hoff, D., Wasserman, T. H., Winer, E. P. and Fister, D. G. (1999) American Society of Clinical Oncology clinical practice guidelines for use of chemotherapy and radiotherapy protectants. J. Clin. Oncol. 17: 3333-3355.
53. Links, M. and Lewis, C. (1999) Chemoprotectants: a review of their clinical pharmacology and therapeutic efficiency Drugs. 57: 293-308.
54. Morais, M. M., Belarmino, F. J. N., Brito, G. A. and Ribeiro, R. A. (1999) A phase II study of ifosfamide, 5-fuorouracil and leucovorin ininduced hemorrhagic cystitis - comparison of the effects of dexamethasone and mesna. Braz. J., Med. Biol. Res. 32: 1211-1215.
55. Highly, M. S., Underhill, C. R., Parnis, F. X., Karapetis, C., Rankin, E., Dussek, J., Bryant, B., Rowland, C., Hodson, N., Hughes, J. and Harper, P. G. (1999) Treatment of invasive thymoma with single agent ifosfamide. J. Clin. Oncol, 17: 2737-2744.
56. Kleta, R. (1999) Cyclophosphamide and mercaptoethanesulfonate therapy for minimal lesion glomerulonephritis. Kidney Int., 56: 2312-2313.
57. Khojasteh, N. H., Zakerinia, M., Ramzi, H. and Haghshenas, M. (2000) A new regimen of MESNA (2-mercaptoethanesulfonate) effectively prevents cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplant recipients. Transplant. Proc. 32: 596.
58. Shueng, P. W., Hsu, W. L., Jen, Y. M., Wu, C. J. and Liu, H. S. (1998) Neoadjuant chemotherapy followed by radiotherapy should not be a standard approach for locally advanced cervical cancer. Int. J. Radiat. Oncol. Biol. Phys. 40: 889-896.
59. Tan, E. H., Wee, J. Ang, P. T., Fong, K. W., Leong, S. S., Khoo, K. S., Tan, T., Lee, K. S., Eng, P., Hsu, A., Tan, Y. K., Chua, E. J. and Ong, Y. Y. (1999) Induction of chemotherapy followed by concurrent chemoradiotherapy in stage III unresectable non-small cell lung cancer. Acta Oncol. 38: 1005-1009.
60. Matsubara, J., Tajima, Y. and Karasawa, M. (1987) Metallothionine induction as a potent means of radiation protection in mice. Radiat. Res. 111: 267-275.
61. Renan, M. J. and Dowmaw, P. I. (1989) Increased radioresistance of tumour cells exposed to metallothionine inducing agents. Radiat.Res. 120: 442-455.
62. Bakka, A., Johnsen, A. S., Endressen, L. and Rugstad, H. E. (1982) Radioresistance in cells with high content of metallothionine. Experientia 38: 381-383.
63. Kagi, J. H. R. and Schaffer, A. (1988) Biochemistry of metallothionine. Biochemistry 27: 8509-8515.
64. Satoh, M., Miura, N., Naganuma, A., Matsuzaki, N., Kawamura, E. and Imura, N. (1989) Prevention of adverse effects of gamma ray irradiation after metallothionine induction by bismuth subnitrate in mice. Eur. J. Cane. Clin. Oncol. 25: 1729-1731.
65. Miko, S., Yanai, T., Hasegawa, H., Akata, N., Kanaiwa-Kudo, S., Matsumoto, T., Noda, Y., Otsu, H. and Sato, F. (1998) Concentration of metallothionin in mice livers after small dose of irradiation. J. Radiat.Res. 39: 239-242.
66. Murata, R., Nishimura, Y., Hiraoka, M., Abe, M. and Satoh, M. (1995) Maganese chloride treatment does not protect against acute radiation injury of skin or crypt cells. Radiat. Res. 143: 316-319
67. Filiat, C., Rodrigues-Gil, J. E. and Guinovart, J. J. (1992) Molybdate and tungstate act like vanadate on glucose metabolism in isolated hepatocytes. Biochem. J. 282: 659-663.
68. Hwang, P. L. and Ryan, R. J. (1981) Tungstate stimulates adenylate cyclase. Endocrinology 108: 435-439.
69. Zaporowska, H. and Wasilewski, W. (1992) Haematological results of vanadium intoxication in Wistar rats. Comp. Biochem. Physiol. 101C: 57-61.
70. 60Co γ-rays in Wistar rats. J. Radiat. Res. 40: 101-113.
71. Pujol, J. L., Gibney, D. J., Su, J. Q., Maksymiuk, A. W. and Jer, J. R. (1993) Immune response induced in small cell lung cancer by maintenance with interferon gamma. J.Natl.Cancer Inst. 85: 1844-1850.
72. Real, A., Guenechea, G., Bueren, J. A. and Maganto, G. (1992) Radioprotection mediated by the haemopoietic stimulation conferred by AM5: a protein-associated polysaccharide. Int. J. Radiat. Biol. 62: 65-72.
73. Guenechea, G., Albella, B., Bueren, J. A., Maganto, G., Tuduri, P., Guerreo, A., Pivel, J. P. and Real, A (1997) AM218, a new polyanionic polysaccharide, induces radioprotection in mice when administered shortly before irradiation. Int. J. Radiat. Biol. 71: 101-108.
74. Furuse, M., Tsuneoka, K., Uchida, K. and Nomoto, K. (1997) Acceleration of granulocytic cell recovery in irradiated mice by a single subcutaneous injection of a heat killed Lactobacillus casei preparation. J. Radiat. Res. 38: 111-120.
75. Fedorocko, P., Brezani, P. and Mackova, N. O. (1992) Radioprotection of mice by the bacterial extract Broncho-Vaxom: haemopoietic stem cells and survival enhancement. Int.J.Radiat.Biol. 61: 511-518.
76. Fedorocko, F. and Mackova, O. (1996) Radioprotective effects of combination broncho-vaxom, a macrophage activator and indomethacin, an inhibitor of prostaglandin production: relationship to myelopoiesis. Eur. J. Haematol. 56: 54-61.
77. Landauer, M. R., McChesney, D. G. and Ledney, G. D. (1997) Synthetic trehalose dicorynomycolate (S-TDCM): behavioral effects and radioprotection. J. Radiat. Res. 38: 45-54.
78. Landauer, M. R., McChesney, D. G. and Ledney, G. D. (1997) Synthetic trehalose dicorynomycolate (S-TDCM): behavioral effects and radioprotection. J. Radiat. Res. 38: 45-54.
79. Kalechman, Y., Shani, A., Albeck, M. and Sredni, B. (1995) Induction od acute phase proteins in mice and humans by treatment with AS101, an immunomodulator with radioprotective properties. Immunopharmacology 29: 149-158.
80. Kalechman, Y., Zuloff, A., Albeck, M. and Strassmann, G. (1995) Role of endogenous cytokines secretion in radioprotection conferred by the immunomodulator Ammonium trichloro-(dioxyethylene-0,0')tellurate. Blood 85: 1555-1561.
81. Weiss, J. F. and Simic, M. G. (1988) Introduction: Perspectives in Radiation Protection. Pharmacol. Ther. 39: 1-2.
82. Neta, R. (1988) Role of cytokines in radiation protection. Pharmacol. Ther. 39: 261-266.
83. Neta, R., Douches, S. D. and Oppenheim, J. J. (1986) Interlukin I is a radioprotector. J. Immunol. 136: 2483-2485
84. Riehl, T., Cohen, S., Tessner, T., Scholemann, S. and Stenson, W. S. (2000) Lipopolysaccharide is radioprotective in mouse intestine through a prostaglandin mediated mechanism. Gastroenterology 118: 1106-1116.
85. 2 is equally effective in male and female mice. J. Radiat. Res. 36: 1-7.
86. Joshima, H., Ohara, H. and Aoki, Y. (1992) The effect of OK-432 upon erythropoietic recovery in sub-lethally irradiated mice: A preliminary report. J. Radiat. Res. 33: 290-300.
87. Needleman, P., Turk, J., Morrison, A. R. and Letkowith, J. B. (1986) Arachidonic acid metabolism. Ann. Rev. Biochem. 55: 69-102.
88. Hanson, W. R., Houseman, K. A. and Collins, P. W. (1988) Radiation protection in vivo by prostaglandins and related compounds of the arachidonic acid cascade. Pharmacol. Ther. 39: 347-356.
89. 2 increases survival in mice following irradiation. Radiat. Res. 109: 440-448.
90. Hanson, W. R., Zhen, W., Geng, L., Hunter, N. and Milas, L. (1995) The prostaglandin E1 analog, misoprostol, a normal tissue protector, does not protect four murine tumors in vivo from radiation injury. Radiat. Res. 142: 281-287.
91. 1 analogue misoprostol in DNA repair -proficient and -deficient rodent cell systems. Radiat. Res. 152: 398-403.
92. Martin, R. F., Broadhurst, S., D'Abrew, S., Budd, R., Sephton, R., Reum, M. and Kelly, D. P. (1996) Radio-protection by DNA ligands. Br. J. Cancer Suppl. 27: S99-101.
93. Martin, R. F. and Anderson, R. F. (1999) Pulse radiolysis studies indicate that electron transfer is involved in radioprotection by Hoechst 33342 and methylproamine. InI. J. Radiat. Oncol. Biol. Phys. 42: 827-831.
94. Harshman, K. D. and Dervan, P. B. (1985) Molecular recognition of B-DNA by Hoechst 33258. Nucleic Acids Res. 13: 4825-4835.
95. 125I labeled ligand to probe DNA structure. Nature 302: 452-454.
96. Denison, L., Haigh, A., D'Cunha, G. and Martin, F. (1992) DNA ligands as radioprotectors: molecular studies with Hoechst 33342 and Hoechst 33258. Int. J. Radiat. Biol. 61: 69-81.
97. Holt, J. A. (1975) The principles of hyperbaric and anoxic radiotherapy. Br. J. Radiol. 48: 819-826.
98. Halliwell, B. and Gutteridge, J. M. C. (1999) Free radicals in Biology and Medicine. Scection 2.4.5. Sulphur radicals. Third edition, Oxford Science Publications, Oxford.
99. Yuhas, J. M. (1982) Protective drugs in cancer therapy: Optimal clinical testing and future directions. Int. J. Radiat. Oncol. Biol. Phys. 8: 513-517.
100. Kollmann, G., Yuhas, J. M., Leone, S. and Shapiro, B. (1973) Mechanism of differential radiation protection of normal versus tumor tissues by WR2721 in tumor bearing mice. Radiat. Res. 55: 603.
101. Eldjarn, L. and Phil. A. (1958) Cysteine and cysteamine group of protective agents: chemical structure, protective ability and mixed disulfide formation. Radiat. Res. 9: 110.
102. Bryant, P. (1985) Enzymatic restriction of mammalian cell DNA: evidence for double strand breaks and potentially lethal lesions. Int. J. Radiat. Biol. 48: 55-60.
103. Radford, I. (1985) The level of induced DNA double strand breaks correlates with cell killing after X-irradiation. Int. J. Radiat. Biol. 48: 45-54.
104. Kohn, K. W. (1979) DNA as target in cancer chemotherapy. Measurement of macromolecular DNA damage produced in mammalian cells by anticancer agents and carcinogens. Meth. Cancer Res. 16: 297-345.
105. Orr, J. S. (1984) Cocepts, problems and the role of modifying agents in the relationship between recovery of cells' survival ability and mechanisms of repair of radiation lesions. Br. J. Cancer 49 (suppl. 6): 1-6.
106. Friedberg, E. C. (1985) DNA repair, Freeman, New York.
107. Roizin Towle, L., Hall, E. J. and Costello, T. (1984) Chemosensitization: Do thiols matter? Int. J. Radiat. Oncol. Biol. Phy. 10: 1599-1602.
108. Bump, E. A., Yu, N. Y. and Brown, J. M. (1981) The use of drugs which deplete intracellular glutathione in hypoxic cell radiosensitization. Int. J. Radiat. Oncol. Biol. Phy. 8: 439-442.
109. Bump, E. A. and Yu, N. Y. (1982) Radiosensitization of hypoxic tumor cells by depletion of intracellular glutathione. Science 217: 544-549.
110. Bertsche, U. and Schorn, H. (1986) Glutathione depletion by dl-buthione-SR-sulfoximine (BSO) potentiates X-ray induced chromosome lesions after liquid holding recovery. Radiat. Res. 105: 351-369.
111. Clark, E. P., Epp, F. R. and Biaglow, J. E. (1984) Glutathione depletion, radiosensitization and misonidazole potentiation in hypoxic Chinese hamster ovary cells by butathione. Radiat. Res. 98: 370-380.
112. Revesz, L. (1985) The role of endogenous thiols in intrinsic radioprotection. Int. J. Radiat. Biol. 47: 361-368.
113. Edgreen, M., Revesz, L. and Larson, A. (1981) Induction and repair of single strand DNA breaks after X-irradiation of human fibroblasts deficient in glutathione. Int. J. Radiat. Biol. 40: 355-363.
114. Edgreen, M. (1983) Depletion of cellular thiols by misonidazole pretreatment prevent some post irradiation repair processes. Br. J. Radiol. 56: 211-212.
115. Revesz, L. and Edgreen, M. (1984) Glutathione dependent yield and repair of single strand DN breaks in irradiated cells. Br. J. Cancer 49 (suppl. 6): 55-60.
116. Belli, J. A. and Shelton, M. (1969) Potentially lethal radiation damage : Repair by mammalian cells in culture. Science 165: 490-492.
117. Pulatova, M. K., Sharygin, V. L. and Todorov, I. N. (1999) The activation of ribonucleotide reductase in animal organs as the cellular response against the treatment with DNA damaging factors and the influence of radioprotectors on this effect. Biochim. Biophys. Acta. 1453: 321-329.
118. Filatov, D., Bjorklund, S., Johansson, E. and Thelander, L. (1996) Induction of the mouse ribonucleotide reductase R1 and R2 genes in response to DNA damage by UV light. J. Biol. Chem. 271: 23698-23704.
119. Hurta, R. A. R. and Wright, J. A. (1992) Alterations in the activity and regulation of mammalian ribonucleotide reductase by chlorambucil, a DNA damaging agent. J. Biol.Chem. 267: 7066-7071.
120. Tanaka, H., Arakawa, H., Yamaguchi, T., Shiraishi, K., Fukuda, S., Matsui, K., Takei, Y. and Nakamura, Y. (2000) A ribonucleotide reductase gene involved in a p53-dependent cell cycle check point for DNA damage. Nature 404: 42-49.